Four months after Theravance…
Four months after Theravance Biopharma shut down its R&D unit, [...]
Four months after Theravance Biopharma shut down its R&D unit, [...]
Sobi’s plan to introduce a challenger to Amgen’s blockbuster gout [...]
The FDA has approved Viridian Therapeutics’ thyroid eye disease treatment, [...]
The agency spotted seven observations at Dr. Reddy’s Bachupally, Hyderabad, [...]
The European Commission has kicked off formal proceedings in an [...]
As Amgen prepares to defend Tavneos’ market approval in the [...]
In the past two weeks, CARsgen won the world’s first [...]
Eli Lilly is having a Total Recall moment, using cutting-edge [...]
BeOne Medicines has extended its relationship with Blood Cancer United, [...]
Held just after the prestigious Cannes Film Festival in southern [...]